跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONZAPIN ODT ORODISPERSIBLE TABLET 5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
ONZAPIN ODT ORODISPERSIBLE TABLET 5 MG
Approved
THERAPEUTIC
ONZAPIN ODT ORODISPERSIBLE TABLET 5 MG
ACTAVIS LTD. (MALTA)
🇸🇬 Health Sciences Authority
Approval Date
May 5, 2011
Approval ID
a4a68814b29195a7
Company
ACTAVIS LTD. (MALTA)
Type
Therapeutic
Approval Details
Approval Id
a4a68814b29195a7
Drug Name
ONZAPIN ODT ORODISPERSIBLE TABLET 5 MG
Product Name
ONZAPIN ODT ORODISPERSIBLE TABLET 5 MG
Approval Number
SIN13957P
Approval Date
2011-05-05
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route Of Administration
ORAL
Atc Code
N05AH03
Atc Item Name
olanzapine
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
Olanzapine (form 1)
5.0 mg
OLANZAPINE (FORM 1)
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 5, 2011
Approval ID
a4a68814b29195a7
Type
Therapeutic
Back to HSA Approvals